Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation by Jia-Jun Wu, MD, Po-Hsin Lee, MD, Zhe-Rong Zheng, MD, Yen-Hsiang Huang, MD, Jeng-Sen Tseng, MD, PhD, Kuo-Hsuan Hsu, MD, Tsung-Ying Yang, MD, PhD, Sung-Liang Yu, PhD, Kun-Chieh Chen, MD, PhD, Gee-Chen Chang, MD, PhD

Get full text

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial by Zhang, Li, Prof, Huang, Yan, MD, Hong, Shaodong, MD, Yang, Yunpeng, MD, Yu, Gengsheng, MD, Jia, Jun, MD, Peng, Peijian, MD, Wu, Xuan, MD, Lin, Qing, Prof, Xi, Xuping, Prof, Peng, Jiewen, MD, Xu, Mingjun, MD, Chen, Dongping, Prof, Lu, Xiaojun, MD, Wang, Rensheng, MD, Cao, Xiaolong, MD, Chen, Xiaozhong, MD, Lin, Zhixiong, Prof, Xiong, Jianping, MD, Lin, Qin, MD, Xie, Conghua, MD, Li, Zhihua, MD, Pan, Jianji, Prof, Li, Jingao, MD, Wu, Shixiu, Prof, Lian, Yingni, MD, Yang, Quanlie, MD, Zhao, Chong, Prof

Get full text